Acumen Pharmaceuticals (ABOS) Price to Book (2021 - 2026)

Acumen Pharmaceuticals has disclosed Price to Book across 6 years of filings, most recently posting 3.37 for Q2 2026.

• In Q2 2026, Price to Book rose 461.82% year-over-year to 3.37; the TTM figure through Jun 2026 stood at 3.37 (up 461.82% YoY), while the FY2025 annual figure was 1.81, up 219.22% from the prior year.
• Price to Book came in at 3.37 for Q2 2026 at Acumen Pharmaceuticals, up from 1.95 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 3.37 in Q2 2026 to a low of 0.43 in Q1 2025.
• Average Price to Book over 5 years is 1.15, with a median of 0.93 recorded in 2022.
• Year-over-year, Price to Book sank 58.49% in 2023 and soared 461.82% in 2026.
• Over 5 years, Price to Book stood at 1.17 in 2022, then retreated by 29.02% to 0.83 in 2023, then tumbled by 31.75% to 0.57 in 2024, then jumped by 219.22% to 1.81 in 2025, then surged by 85.8% to 3.37 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 3.37 in Q2 2026, 1.95 in Q1 2026, and 1.81 in Q4 2025.